{"id":12344,"date":"2024-07-24T14:35:07","date_gmt":"2024-07-24T12:35:07","guid":{"rendered":"https:\/\/iph-multisite.berta-bewegt.ch\/?p=12344"},"modified":"2026-03-03T10:37:02","modified_gmt":"2026-03-03T09:37:02","slug":"communique-de-presse-lapprovisionnement-en-medicaments-est-en-danger-le-marche-suisse-perd-de-son-attrait","status":"publish","type":"post","link":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lapprovisionnement-en-medicaments-est-en-danger-le-marche-suisse-perd-de-son-attrait\/","title":{"rendered":"Communiqu\u00e9 de presse &#8211; L\u2019approvisionnement en m\u00e9dicaments est en danger: le march\u00e9 suisse perd de son attrait"},"content":{"rendered":"\n<p class=\"is-style-paragraph-lead-text\"><strong>En Suisse, les patients-e-s acc\u00e8dent de moins en moins facilement \u00e0 des m\u00e9dicaments parfois vitaux. L\u2019\u00e9tude de benchmarking men\u00e9e par Swissmedic et l\u2019industrie a mis encore davantage en \u00e9vidence le vrai probl\u00e8me auquel la Suisse est confront\u00e9e. En effet, le processus de l\u2019OFSP visant \u00e0 fixer le prix des m\u00e9dicaments et \u00e9tablir les modalit\u00e9s de leur prise en charge prend toujours plus de temps, et les conditions-cadres se p\u00e9jorent, ce qui rend le march\u00e9 suisse moins attrayant. Cette situation est probl\u00e9matique pour l\u2019industrie pharmaceutique, et surtout pour les patient-e-s. Des solutions existent, mais au lieu de proc\u00e9der \u00e0 des r\u00e9formes pourtant urgentes, la sph\u00e8re politique aggrave la situation.<\/strong><\/p>\n\n\n\n<p>L\u2019\u00e9tude de benchmarking&nbsp;2023 r\u00e9alis\u00e9e par l\u2019industrie pharmaceutique et Swissmedic montre que la dur\u00e9e des processus d\u2019autorisation de mise sur le march\u00e9 a augment\u00e9 en Suisse, et que les entreprises soumettent leurs demandes plus tardivement. Par cons\u00e9quent, en Suisse, un m\u00e9dicament est autoris\u00e9 249&nbsp;jours (m\u00e9diane calcul\u00e9e \u00e0 partir de l\u2019ensemble des processus) plus tard qu\u2019aupr\u00e8s de l\u2019Agence europ\u00e9enne des m\u00e9dicaments (EMA). Par ailleurs, une augmentation du retard de 48% est constat\u00e9e par rapport \u00e0 l\u2019ann\u00e9e pr\u00e9c\u00e9dente. Concr\u00e8tement, en 2023, les entreprises ont d\u00e9pos\u00e9 leur demande d\u2019autorisation de mise sur le march\u00e9 aupr\u00e8s de Swissmedic 244&nbsp;jours (m\u00e9diane calcul\u00e9e \u00e0 partir de l\u2019ensemble des proc\u00e9dures) apr\u00e8s celle adress\u00e9e \u00e0 l\u2019EMA. Cela ralentit encore davantage les processus. Les r\u00e9glementations politiques actuelles sont en cause: la d\u00e9t\u00e9rioration des conditions-cadres fait en sorte qu\u2019on accorde de moins en moins la priorit\u00e9 au march\u00e9 suisse. Cela nuit \u00e0 l\u2019industrie phar\u00admaceutique, et surtout aux patient-e-s qui r\u00e9sident en Suisse.<\/p>\n\n\n\n<p>Ren\u00e9&nbsp;Buholzer, directeur d\u2019Interpharma, d\u00e9clare \u00e0 ce sujet:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p><em>\u00abAlors que les milieux politiques se focalisent enti\u00e8rement sur les co\u00fbts, la s\u00e9curit\u00e9 de l\u2019approvisionnement en p\u00e2tit, et les laboratoires pharmaceutiques qui ont des sites de recherche et de production sur notre territoire n\u2019arrivent plus \u00e0 planifier leurs op\u00e9rations. La Conf\u00e9d\u00e9ration et le Parlement doivent revoir enti\u00e8rement l\u2019acc\u00e8s des patient-e-s aux m\u00e9dicaments innovants, afin d\u2019\u00e9viter que l\u2019industrie et l\u2019approvi\u00adsionnement en m\u00e9dicaments ne subissent des r\u00e9percussions sur le long terme.\u00bb<\/em><\/p>\n<\/blockquote>\n\n\n\n<p>Malheureusement, les r\u00e9sultats de l\u2019\u00e9tude WAIT (<em>Patients W.A.I.T Indicator<\/em>) de l\u2019EFPIA confirment les effets n\u00e9fastes de cette situation puisque, d\u2019apr\u00e8s ces donn\u00e9es, <a href=\"https:\/\/interpharma.ch\/blog\/communique-de-presse-disponibilite-des-medicaments-la-suisse-perd-du-terrain\/?lang=fr\">seule la moiti\u00e9 des m\u00e9dicaments pris en charge en Allemagne sont \u00e9galement facile\u00adment accessibles aux patient-e-s suisses<\/a>. Par ailleurs, selon des donn\u00e9es d\u2019Interpharma montrent que le d\u00e9lai d\u2019attente pour acc\u00e9der aux m\u00e9dicaments est d\u00e9sormais de 301\u00a0jours, depuis leur autorisation jusqu\u2019\u00e0 leur prise en charge par la caisse maladie.<\/p>\n\n\n\n<p><strong>D\u00e9p\u00f4ts de demande pour des nouvelles substances actives, toutes proc\u00e9dures (2021 \u2013 2023)<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/interpharma.ch\/wp-content\/uploads\/2024\/07\/Benchmarking_FR-1024x523.png\" alt=\"\" class=\"wp-image-25197\"\/><figcaption class=\"wp-element-caption\">\u00c9tude de benchmarking: la dur\u00e9e de traitement par Swissmedic augmente, et avec elle le \u00abretard\u00bb par rapport \u00e0 l\u2019EMA. L\u2019\u00e9cart entre les dates de soumission (submission gap) se d\u00e9finit comme l\u2019intervalle entre la date de d\u00e9p\u00f4t aupr\u00e8s de l\u2019autorit\u00e9 partenaire et la date de d\u00e9p\u00f4t aupr\u00e8s de Swissmedic. L\u2019\u00e9cart entre les dates d\u2019autorisation (approval gap), quant \u00e0 lui, se d\u00e9finit comme l\u2019intervalle entre la date d\u2019autorisation de l\u2019autorit\u00e9 partenaire et la date d\u2019autorisation de Swissmedic.<\/figcaption><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>En Suisse, les patients-e-s acc\u00e8dent de moins en moins facilement \u00e0 des m\u00e9dicaments parfois vitaux. L\u2019\u00e9tude de benchmarking men\u00e9e par Swissmedic et l\u2019industrie a mis encore davantage en \u00e9vidence le vrai probl\u00e8me auquel la Suisse est confront\u00e9e. En effet, le processus de l\u2019OFSP visant \u00e0 fixer le prix des m\u00e9dicaments et \u00e9tablir les modalit\u00e9s de [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3272,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"tags":[54,122,140],"class_list":["post-12344","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-medien-fr","tag-communique-de-presse","tag-acces-a-linnovation"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Communiqu\u00e9 de presse - L\u2019approvisionnement en m\u00e9dicaments est en danger: le march\u00e9 suisse perd de son attrait - Interpharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lapprovisionnement-en-medicaments-est-en-danger-le-marche-suisse-perd-de-son-attrait\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Communiqu\u00e9 de presse - L\u2019approvisionnement en m\u00e9dicaments est en danger: le march\u00e9 suisse perd de son attrait\" \/>\n<meta property=\"og:description\" content=\"En Suisse, les patients-e-s acc\u00e8dent de moins en moins facilement \u00e0 des m\u00e9dicaments parfois vitaux. L\u2019\u00e9tude de benchmarking men\u00e9e par Swissmedic et l\u2019industrie a mis encore davantage en \u00e9vidence le vrai probl\u00e8me auquel la Suisse est confront\u00e9e. En effet, le processus de l\u2019OFSP visant \u00e0 fixer le prix des m\u00e9dicaments et \u00e9tablir les modalit\u00e9s de [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lapprovisionnement-en-medicaments-est-en-danger-le-marche-suisse-perd-de-son-attrait\/\" \/>\n<meta property=\"og:site_name\" content=\"Interpharma\" \/>\n<meta property=\"article:published_time\" content=\"2024-07-24T12:35:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-03T09:37:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/07\/Therapie.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2121\" \/>\n\t<meta property=\"og:image:height\" content=\"1414\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"berta_admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:site\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"berta_admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lapprovisionnement-en-medicaments-est-en-danger-le-marche-suisse-perd-de-son-attrait\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lapprovisionnement-en-medicaments-est-en-danger-le-marche-suisse-perd-de-son-attrait\/\"},\"author\":{\"name\":\"berta_admin\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818\"},\"headline\":\"Communiqu\u00e9 de presse &#8211; L\u2019approvisionnement en m\u00e9dicaments est en danger: le march\u00e9 suisse perd de son attrait\",\"datePublished\":\"2024-07-24T12:35:07+00:00\",\"dateModified\":\"2026-03-03T09:37:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lapprovisionnement-en-medicaments-est-en-danger-le-marche-suisse-perd-de-son-attrait\/\"},\"wordCount\":617,\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lapprovisionnement-en-medicaments-est-en-danger-le-marche-suisse-perd-de-son-attrait\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/07\/Therapie.jpg\",\"keywords\":[\"M\u00e9dias\",\"Communiqu\u00e9 de presse\",\"acc\u00e8s \u00e0 l'innovation\"],\"inLanguage\":\"fr-FR\",\"copyrightYear\":\"2024\",\"copyrightHolder\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lapprovisionnement-en-medicaments-est-en-danger-le-marche-suisse-perd-de-son-attrait\/\",\"url\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lapprovisionnement-en-medicaments-est-en-danger-le-marche-suisse-perd-de-son-attrait\/\",\"name\":\"Communiqu\u00e9 de presse - L\u2019approvisionnement en m\u00e9dicaments est en danger: le march\u00e9 suisse perd de son attrait - Interpharma\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lapprovisionnement-en-medicaments-est-en-danger-le-marche-suisse-perd-de-son-attrait\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lapprovisionnement-en-medicaments-est-en-danger-le-marche-suisse-perd-de-son-attrait\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/07\/Therapie.jpg\",\"datePublished\":\"2024-07-24T12:35:07+00:00\",\"dateModified\":\"2026-03-03T09:37:02+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lapprovisionnement-en-medicaments-est-en-danger-le-marche-suisse-perd-de-son-attrait\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lapprovisionnement-en-medicaments-est-en-danger-le-marche-suisse-perd-de-son-attrait\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lapprovisionnement-en-medicaments-est-en-danger-le-marche-suisse-perd-de-son-attrait\/#primaryimage\",\"url\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/07\/Therapie.jpg\",\"contentUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/07\/Therapie.jpg\",\"width\":2121,\"height\":1414},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lapprovisionnement-en-medicaments-est-en-danger-le-marche-suisse-perd-de-son-attrait\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/www.interpharma.ch\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Communiqu\u00e9 de presse &#8211; L\u2019approvisionnement en m\u00e9dicaments est en danger: le march\u00e9 suisse perd de son attrait\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.interpharma.ch\/#website\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"name\":\"Interpharma\",\"description\":\"Verband der forschenden Pharmazeutischen Firmen\",\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.interpharma.ch\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.interpharma.ch\/#organization\",\"name\":\"Interpharma\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"contentUrl\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"width\":\"1200\",\"height\":\"1200\",\"caption\":\"Interpharma\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/interpharma_ch\",\"https:\/\/ch.linkedin.com\/company\/interpharma\",\"https:\/\/www.instagram.com\/interpharma_ch\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818\",\"name\":\"berta_admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"caption\":\"berta_admin\"},\"sameAs\":[\"https:\/\/interpharma.ch\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Communiqu\u00e9 de presse - L\u2019approvisionnement en m\u00e9dicaments est en danger: le march\u00e9 suisse perd de son attrait - Interpharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lapprovisionnement-en-medicaments-est-en-danger-le-marche-suisse-perd-de-son-attrait\/","og_locale":"fr_FR","og_type":"article","og_title":"Communiqu\u00e9 de presse - L\u2019approvisionnement en m\u00e9dicaments est en danger: le march\u00e9 suisse perd de son attrait","og_description":"En Suisse, les patients-e-s acc\u00e8dent de moins en moins facilement \u00e0 des m\u00e9dicaments parfois vitaux. L\u2019\u00e9tude de benchmarking men\u00e9e par Swissmedic et l\u2019industrie a mis encore davantage en \u00e9vidence le vrai probl\u00e8me auquel la Suisse est confront\u00e9e. En effet, le processus de l\u2019OFSP visant \u00e0 fixer le prix des m\u00e9dicaments et \u00e9tablir les modalit\u00e9s de [&hellip;]","og_url":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lapprovisionnement-en-medicaments-est-en-danger-le-marche-suisse-perd-de-son-attrait\/","og_site_name":"Interpharma","article_published_time":"2024-07-24T12:35:07+00:00","article_modified_time":"2026-03-03T09:37:02+00:00","og_image":[{"width":2121,"height":1414,"url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/07\/Therapie.jpg","type":"image\/jpeg"}],"author":"berta_admin","twitter_card":"summary_large_image","twitter_creator":"@interpharma_ch","twitter_site":"@interpharma_ch","twitter_misc":{"\u00c9crit par":"berta_admin","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lapprovisionnement-en-medicaments-est-en-danger-le-marche-suisse-perd-de-son-attrait\/#article","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lapprovisionnement-en-medicaments-est-en-danger-le-marche-suisse-perd-de-son-attrait\/"},"author":{"name":"berta_admin","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818"},"headline":"Communiqu\u00e9 de presse &#8211; L\u2019approvisionnement en m\u00e9dicaments est en danger: le march\u00e9 suisse perd de son attrait","datePublished":"2024-07-24T12:35:07+00:00","dateModified":"2026-03-03T09:37:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lapprovisionnement-en-medicaments-est-en-danger-le-marche-suisse-perd-de-son-attrait\/"},"wordCount":617,"publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"image":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lapprovisionnement-en-medicaments-est-en-danger-le-marche-suisse-perd-de-son-attrait\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/07\/Therapie.jpg","keywords":["M\u00e9dias","Communiqu\u00e9 de presse","acc\u00e8s \u00e0 l'innovation"],"inLanguage":"fr-FR","copyrightYear":"2024","copyrightHolder":{"@id":"https:\/\/www.interpharma.ch\/#organization"}},{"@type":"WebPage","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lapprovisionnement-en-medicaments-est-en-danger-le-marche-suisse-perd-de-son-attrait\/","url":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lapprovisionnement-en-medicaments-est-en-danger-le-marche-suisse-perd-de-son-attrait\/","name":"Communiqu\u00e9 de presse - L\u2019approvisionnement en m\u00e9dicaments est en danger: le march\u00e9 suisse perd de son attrait - Interpharma","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lapprovisionnement-en-medicaments-est-en-danger-le-marche-suisse-perd-de-son-attrait\/#primaryimage"},"image":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lapprovisionnement-en-medicaments-est-en-danger-le-marche-suisse-perd-de-son-attrait\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/07\/Therapie.jpg","datePublished":"2024-07-24T12:35:07+00:00","dateModified":"2026-03-03T09:37:02+00:00","breadcrumb":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lapprovisionnement-en-medicaments-est-en-danger-le-marche-suisse-perd-de-son-attrait\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lapprovisionnement-en-medicaments-est-en-danger-le-marche-suisse-perd-de-son-attrait\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lapprovisionnement-en-medicaments-est-en-danger-le-marche-suisse-perd-de-son-attrait\/#primaryimage","url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/07\/Therapie.jpg","contentUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2024\/07\/Therapie.jpg","width":2121,"height":1414},{"@type":"BreadcrumbList","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/communique-de-presse-lapprovisionnement-en-medicaments-est-en-danger-le-marche-suisse-perd-de-son-attrait\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.interpharma.ch\/fr\/"},{"@type":"ListItem","position":2,"name":"Communiqu\u00e9 de presse &#8211; L\u2019approvisionnement en m\u00e9dicaments est en danger: le march\u00e9 suisse perd de son attrait"}]},{"@type":"WebSite","@id":"https:\/\/www.interpharma.ch\/#website","url":"https:\/\/www.interpharma.ch\/","name":"Interpharma","description":"Verband der forschenden Pharmazeutischen Firmen","publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.interpharma.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.interpharma.ch\/#organization","name":"Interpharma","url":"https:\/\/www.interpharma.ch\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/","url":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","contentUrl":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","width":"1200","height":"1200","caption":"Interpharma"},"image":{"@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/interpharma_ch","https:\/\/ch.linkedin.com\/company\/interpharma","https:\/\/www.instagram.com\/interpharma_ch\/"]},{"@type":"Person","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818","name":"berta_admin","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","caption":"berta_admin"},"sameAs":["https:\/\/interpharma.ch"]}]}},"_links":{"self":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/12344","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/comments?post=12344"}],"version-history":[{"count":1,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/12344\/revisions"}],"predecessor-version":[{"id":12345,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/12344\/revisions\/12345"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media\/3272"}],"wp:attachment":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media?parent=12344"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/tags?post=12344"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}